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Selection of Molecular Structure and Delivery of RNA
Oligonucleotides to Activate TLR7 versus TLR8 and to Induce
High Amounts of IL-12p70 in Primary Human Monocytes1
Andrea Ablasser,*† Hendrik Poeck,*† David Anz,† Michael Berger,† Martin Schlee,*
Sarah Kim,† Carole Bourquin,† Nadege Goutagny,§ Zhaozhao Jiang,§ Katherine A. Fitzgerald,§
Simon Rothenfusser,†‡ Stefan Endres,† Gunther Hartmann,2,3* and Veit Hornung2*
Detection of non-self RNA by TLRs within endosomes and by retinoic acid-inducible gene I (RIG-I)-like helicases in the cytosol is central
to mammalian antiviral immunity. In this study, we used pathway-specific agonists and targeted delivery to address RNA immu-
norecognition in primary human immune cells. Within PBMC, plasmacytoid dendritic cells (pDC) and monocytes were found to be
responsible for IFN- production upon immunorecognition of RNA. The mechanisms of RNA recognition in pDC and monocytes were
distinct. In pDC, recognition of ssRNA and dsRNA oligonucleotides was TLR7-dependent, whereas a 5 triphosphate moiety (RIG-I
ligand activity) had no major contribution to IFN- production. In monocytes, the response to RNA oligonucleotides was mediated by
either TLR8 or RIG-I. TLR8 was responsible for IL-12 induction upon endosomal delivery of ssRNA oligonucleotides and RIG-I was
responsible for IFN- production upon delivery of 5 triphosphate RNA into the cytosol. In conclusion, the dissection of these pathways
by selecting the appropriate structure and delivery of RNA reveals pDC as major producer of IFN- upon TLR-mediated stimulation
and monocytes as major producer of IFN- upon RIG-I-mediated stimulation. Furthermore, our results uncover the potential of
monocytes to function as major producers of IL-12p70, a key Th1 cytokine classically ascribed to myeloid dendritic cells that cannot be
induced by CpG oligonucleotides in the human system. The Journal of Immunology, 2009, 182: 6824–6833.
T he presence of viral nucleic acids represents a danger sig-nal for the immune system that initiates an antiviral im-mune response to impede viral replication and to elimi-
nate the invading pathogen (1). To detect foreign nucleic acids,
immune cells are equipped with a set of pattern recognition recep-
tors that act at the frontline of the recognition process and can be
categorized into two major classes. First, members of the family of
TLR have been implicated in the detection of long dsRNA (TLR3;
Ref. 2), ssRNA (TLR7 and 8; Refs. 3 and 4), short dsRNA (TLR7;
Ref. 5), and CpG DNA (TLR9; Ref. 6). These nucleic acid-sensing
TLRs operate mainly within immune cells by responding to viral
nucleic acids that have been ingested by the cell and are incorpo-
rated into endosomal compartments (7). Recently, the discovery of
the cytoplasmic RNA helicases retinoic acid-inducible gene-I
(RIG-I),4 melanoma differentiation-associated gene 5 (MDA5),
and laboratory of genetics and physiology 2 has expanded the rep-
ertoire of the cellular virus-sensing receptors and constitutes a sec-
ond class of immunoreceptors for nucleic acids (8, 9). These he-
licases function collectively as pattern recognition receptors to
detect replicating viruses and their genetic RNA components. As
opposed to TLRs, cytosolic helicases are expressed in a wide spec-
trum of cell types, including immune cells and nonimmune cells
like fibroblasts or epithelial cells (10). Both receptor systems co-
operate to optimize detection of viral RNA.
Given the abundance of host RNA present in the cytoplasm, it
is an intricate task to specifically and reliably sense virus-derived
RNA. Maximal sensitivity and a high degree of specificity for
“non-self” characteristics are required. Two major concepts seem
to be in place to distinguish non-self from self via a protein re-
ceptor-based recognition system: 1) detection of a certain molec-
ular pattern that is specific for the pathogen and does not occur in
the host system and 2) recognition based on pathogen-specific
compartmentalization. For detection of pathogen-derived nucleic
acids both mechanisms apply. Structural signatures exist that allow
immune receptors to determine the origin of RNA. Long dsRNA is
indicative for non-self RNA and has been proposed to stimulate an
IFN response via TLR3 (2), RIG-I (9), and MDA5 (11). The 5
triphosphate moiety of viral RNA transcripts, a characteristic fea-
ture of de novo transcribing RNA polymerases, was identified to
be the ligand for RIG-I (12, 13). Although endogenous host RNA
transcripts also initially contain a 5 triphosphate end, several nu-
clear posttranscriptional modifications of the host RNA, including
5 capping, endonucleolytic cleavage, and base- and backbone
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modifications of the nascent RNA transcript, lead to ignorance by
RIG-I. In addition, blunt-end short dsRNA has been postulated to
stimulate RIG-I (14). A clearly defined molecular pattern has not
been reported for the ssRNA-sensing TLRs (TLR7 and TLR8).
However, the fact that certain sequence motifs are preferred over
others suggests that the composition of nucleotides, on top of en-
dosomal localization, might represent another basis to discriminate
between self and non-self RNA (3–5, 8, 9, 15, 16).
Notably, host RNA can regain the ability to stimulate an IFN
response under certain pathologic situations, indicating that there
is more to the immune system’s definition of “foreign” than the
underlying molecular structure (17–21). In fact, the subcellular
localization of RNA receptors constitutes an important aspect of
RNA recognition. Whereas RIG-I and MDA5 are expressed within
the cytoplasm, TLR7, TLR8, and (in immune cells) TLR3 are po-
sitioned within endosomal compartments (22, 23). The sequestra-
tion of TLRs within certain subcellular compartments is believed
to minimize the chances of encountering host-derived RNA while
simultaneously maximizing the chances of sensing virus-derived
RNA, which enters the cell via the endocytosis pathway.
In this context it is important to keep in mind that RNA, due to
its susceptibility to nuclease degradation, usually requires a cargo
vehicle for protection and cellular delivery. Viral genomic RNA or
DNA is usually protected by a viral capsid, a heterogeneous mem-
brane composed of lipids and proteins. A common strategy har-
nessed to deliver synthetic RNA is to use transfection reagents,
mostly lipid-based formulations.
Detection of viral nucleic acids by the immune system results in
the production of type I IFNs (IFN- and IFN-) and various other
cytokines finally promoting innate and adaptive immunity (1).
Within immune cells, dendritic cells (DC) and monocytes express
the broadest spectrum of nucleic acid-sensing TLRs (24). Plasma-
cytoid DC (pDC) express both TLR7 and TLR9 and are known to
represent the major source of IFN- within peripheral blood. My-
eloid DC (mDC) express TLR3, TLR7, and TLR8 and produce
IL-12, the key cytokine to promote Th1 polarization (25–27).
However, IL-12 induction within DC is tightly controlled (28, 29)
and IL-12 production in monocytes (TLR8) is regarded to be weak.
The use of defined RIG-I ligand triphosphate RNA (3pRNA)
allowed us to uncover the relationship between TLR7 in pDC and
RIG-I and TLR8 in monocytes. In this paper, we identify pDC as
the major source of IFN- in response to endosomal ssRNA and
dsRNA, monocytes as the major source of IFN- in response to
cytoplasmic 3pRNA, and monocytes as the major source of IL-
12p70 in response to endosomal ssRNA. The results presented in
this paper provide a rationale for developing immunostimulatory
oligoribonucleotides as adjuvants for cancer or as antiviral
compounds.
Materials and Methods
Media and reagents
RPMI 1640 (Biochrom) supplemented with 10% (v/v) heat-inactivated
FCS (Invitrogen), 1.5 or 3 mM L-glutamine, 100 U/ml penicillin, and 100
g/ml streptomycin (all from Sigma-Aldrich) was used. Recombinant hu-
man IFN- and IL-3 were purchased from R&D Systems. CpG oligode-
oxynucleotide (ODN) was purchased from Coley Pharmaceutical Group
and was used at a final concentration of 3 g/ml ODN 2216: 5-GGGG
GACGATCGTCGGGGGG-3 (underlined letters, phosphorothioate link-
age at the 3 end of the base; bold letters, CpG dinucleotides). The TLR7/8
agonist R848 was purchased from Invivogen. Polyinosinic:polycytidylic
acid (poly(I:C)) was purchased from Sigma-Aldrich.
Mice
TLR7-deficient mice were kindly provided by S. Akira (Osaka University,
Osaka, Japan). Female C57BL/6 mice were purchased from Harlan-
Winkelmann. Mice were 6–12 wk of age at the onset of experiments.
Animal studies were approved by the local regulatory agency (Regierung
von Oberbayern, Munich, Germany).
Cell culture
pDC from Flt3 ligand-induced bone marrow cultures were sorted with
B220 microbeads (Miltenyi Biotec). Murine primary cells were cultivated
in very low endotoxin RPMI 1640 (Biochrom) supplemented with 10%
FCS, 100 g/ml streptomycin, 100 U/ml penicillin, 3 mM L-glutamine, and
10 mM 2-ME. Human PBMC were isolated from whole human blood of
healthy, voluntary donors by Ficoll-Hypaque density gradient centrifuga-
tion (Biochrom). pDC were positively depleted using magnetically labeled
anti-CD304 Ab (Miltenyi Biotec). pDC isolation was always performed
before the following purification steps to exclude IFN-production by con-
taminating pDC. Untouched monocytes were obtained by negative deple-
tion from PBMC after isolation of pDC with the Human Monocyte Isola-
tion Kit II, according to the manufacturer’s instructions (Miltenyi Biotec).
mDC were purified from PBMC by immunomagnetic sorting with anti-
CD1c beads (CD1c (BDCA-1) Dendritic Cell Isolation Kit, human;
Miltenyi Biotec). Viability of all cells was above 95%, as determined by
trypan blue exclusion. If not indicated otherwise, cells were cultured in
96-well plates for stimulation experiments. mDC (0.5  106/ml) were kept
in RPMI 1640 containing 10% FCS, 1.5 mM L-glutamine, 100 U/ml pen-
icillin, and 100 g/ml streptomycin. pDC (0.25 106/ml) were cultured in
complete medium as described above, supplemented with 10 ng/ml IL-3
(R&D Systems). PBMC (2  106/ml) and monocytes (0.5  106/ml) were
resuspended in RPMI 1640 medium with 2% AB serum (BioWhittaker),
1.5 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin. All
compounds were tested for endotoxin contamination before use.
In vitro cell stimulation and transfection
CpG ODN was used at a final concentration of 3 g/ml. Stimulation with
the TLR7/8 agonist R848 was performed at a concentration of 5 g/ml.
Exogenous stimulation with poly(I:C) without transfection was performed
at doses of 10 g/ml. RNAs were transfected with Lipofectamine 2000
(Invitrogen) according to the manufacturer’s protocol. Cells were trans-
fected with 200 ng of nucleic acid with 0.5 l of Lipofectamine 2000. As
a control we used Lipofectamine 2000 diluted in OptiMEM (Invitrogen)
without nucleic acids. For transfection with the polycationic polypeptide
poly-L-arginine (pLa) (P7762 from Sigma-Aldrich), 239 ng of nucleic acids
diluted in 15 l of PBS (PAA Laboratories) were mixed with 280 ng of
pLa and incubated for 20 min before stimulation. The particle size (600–
700 nm) and  potential (10  5 mV) were determined by dynamic light
scattering, and potentials were measured electrophoretically (Zetasizer
3000HS; Malvern Instruments). Pretreatment with recombinant human
IFN- (PeproTech) was performed at a concentration of 500 U/ml for 3 h
before stimulation. In some experiments, cells were pretreated with chlo-
roquine (Sigma-Aldrich) for 30 min before stimulation. For cytokine as-
says, cells were cultured for 20 to 24 h and supernatants were collected and
assayed for secreted amounts of cytokines.
RNAs
Chemically synthesized RNA oligonucleotides were purchased from Eu-
rogentec or MWG Biotech. For a detailed list of all chemically synthesized
RNA oligonucleotides, see Table I. In vitro transcribed RNAs were syn-
thesized according to the manufacturer’s instructions using the ME-
GAshortscript kit (Ambion). For a detailed list of all in vitro transcription
templates, see Table II. The templates contained a T7 RNA polymerase
consensus promoter followed by the sequence of interest to be transcribed.
An extra guanosine was added at the 5 end to both the sense and the
antisense strands to transcribe with T7 RNA polymerase. The DNA tem-
plate was digested using DNase I (Ambion), and RNAs were purified by
phenol/chloroform extraction and alcohol precipitation. Excess salts and
NTPs were removed by passing the RNAs through a Mini Quick Spin oligo
column (Roche). Integrity of RNAs was checked via gel electrophoresis.
Detection of cytokines by ELISA
The amount of IFN- production was determined using the IFN- module
set from Bender MedSystems. Quantification of IL-12p70, IL-12p40,
TNF-, IFN-, IL-6, IL-8, IL-1, IL-10, and IP-10 was performed using
the respective OptEIA ELISA kits (BD Pharmingen). Quantification of
human RANTES was performed using the human RANTES construction
kit (Antigenix America). ELISAs were performed according to the man-
ufacturer’s protocol. The concentration of cytokines was determined by the
standard curve obtained using known amounts of recombinant cytokines.
For some experiments, murine IFN- was measured according to the fol-
lowing protocol: monoclonal rat anti-mouse IFN- (clone RMMA-1) was
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used as capture Ab and polyclonal rabbit anti-mouse IFN- serum was
used for detection (both from PBL Biomedical Laboratories) together with
HRP-conjugated donkey anti-rabbit IgG as secondary reagent (Jackson Im-
munoResearch Laboratories). Mouse rIFN- (PBL Biomedical Laborato-
ries) was used as standard (IFN- concentration in IU/ml).
Flow cytometry
Cell purity was assessed by FACS analysis of cell surface Ags using a
FACSCalibur (BD Biosciences). Human monocytes were stained with Ab
against CD14-FITC or CD14-allophycocyanin and cell purity was between
83 and 99%. Human pDC were positively labeled with Ab against
CD123-PE and HLA-DR-PerCp and negatively labeled for CD11c-allo-
phycocyanin and a mixture to lineage markers (FITC). Cells were routinely
between 81 and 98% pure. For identification of human mDC, we used Ab
for CD11c-allophycocyanin, HLA-DR-PerCP for positive staining, and
CD123-PE and a mixture to lineage markers for negative staining (cell
purity, 90 and 92%). Abs were purchased from BD Pharmingen. Intracel-
lular staining of cytokines was performed with human PBMC (2 106/ml)
transfected with 3pRNA or synthetic RNA 9.2 sense and cultured for 7 h.
Lipofectamine alone or no stimulus served as controls. After 3 h, brefel-
din-A (10 g/ml) (Sigma-Aldrich) was added to PBMC and cells were
cultured for another 4 h. Cells were washed and diluted in PBS supple-
mented with 1% FCS and cell-surface staining was performed with APC-
conjugated Ab against CD14 (BD Pharmingen). After fixation, cells were
permeabilized with 1% Saponin in PBS/1% FCS and labeled with FITC-
conjugated Ab against human IFN- (PBL Biomedical Laboratories). Data
analysis was performed on viable cells using CellQuest software (BD
Biosciences).
Fluorescence microscopy
Freshly isolated human monocytes (0.5  106/ml) were stimulated with
200 ng FITC-labeled 9.2 sense RNA complexed to pLa (280 ng) or Lipo-
fectamine 2000 (0.5 l in 50 l OPTIMEM) for the indicated durations and
consequently adhered to poly-L-lysine-coated microscope slides. Cells
were then fixed in 100% acetone for 10 min and incubated with Abs di-
rected against EEA-1 (BD Biosciences). Biotinylated rat-anti-mouse
F(ab)2 fragment and rhodamine-red-X-conjugated streptavidin (both Jack-
son ImmunoResearch) were used as secondary reagents. Topro-3 (Invitro-
gen) was used for nuclear counterstaining. Stained cells were visualized
using a fluorescence microscope (Zeiss) and Adobe Photoshop was used
for adjustment of contrast and size.
small interfering RNA (siRNA) electroporation
For siRNA experiments, primary human monocytes were differentiated
into monocyte-derived DCs in the presence of 800 U/ml IL-4 and GM-CSF
(both ImmunoTools). On day 6, cells were harvested, washed, and diluted
in OPTIMEM (Invitrogen). For siRNA electroporation, siRNA duplexes
(7.5 g) targeting human RIG-I, human TLR8, or luciferase were trans-
ferred into a 4-mm cuvette (Thermo Fisher Scientific), filled with 100 l
cell suspension containing 4  105 cells, and pulsed in a GenePulser Xcell
(Bio-Rad) (Instrument settings: Square Wave, 1000 V; 2 pulses, 0.5 ms).
After electroporation, cells were transferred into prewarmed RPMI 1640
medium (2  105 cells/200 l) for another 2 days. Cells were transfected
with RNA or stimulated with R848 as indicated. Supernatants were col-
lected and subjected to ELISA for quantification of cytokines 24 h later.
siRNA sequences for knock-down experiments are shown in Table III and
were all purchased from Eurogentec.
Quantitative real-time PCR
RNA from human monocytes and pDC was extracted using the RNeasy kit
(Qiagen). cDNA was synthesized with the SuperScript VILO cDNA Syn-
thesis Kit (Invitrogen). Quantitative real-time PCR was performed on a
Lightcycler 480 (Roche) using the Maxima SYBR Green qPCR Master
Mix (Fermentas). The specificity of amplification was assessed for each
sample by melting curve analysis. Relative quantification was performed
using standard curve analysis. The quantification data are presented as a
ratio to the hypoxanthine phosphoribosyltransferase 1 (HPRT-1) level. The
following primer for detection of IFN- and HPRT-1 mRNAs were used:
Homo sapiens (hs)HPRT-1, 5-TGA CCT TGA TTT ATT TTG CAT
ACC-3 (forward) and 5-CGA GCA AGA CGT TCA GTC CT-3 (re-
verse); hsIFN-, 5-AAA CTC ATG AGC AGT CTG CA-3 (forward) and
5-AGG AGA TCT TCA GTT TCG GAG G-3 (reverse); hsRIG-I, 5-
AGC TCA GCT TGA TGA GGG ACA-3 (forward) and 5-GTC TGG
CAT CTG GAA CAC CA-3 (reverse); hsMDA5, 5-AGA GTG GCT
GTT TAC ATT GCC-3 (forward), 5-GCT GTT CAA CTA GCA GTA
CTT T-3 (reverse); hsTLR9, 5-CGT CTT GAA GGC CTG GTG TTG
A-3 (forward), 5-CTG GAA GGC CTT GGT TTT AGT GA-3 (reverse).
Results
3pRNA induces IFN- in monocytes, mDC and pDC
Unlike the TLR system, which is confined to certain immune cell
subsets, RIG-I is expressed in a broad spectrum of cell types. In
this paper we studied the sensitivity of primary immune cell sub-
sets to the RIG-I ligand 3pRNA. 3pRNA was transfected using the
cationic lipid Lipofectamine and IFN- production was analyzed.
As controls poly(I:C) (TLR3/MDA5), R848 (TLR7/TLR8), and
CpG-A (TLR9) were used. Poly(I:C) was used with and without
transfection. To increase the sensitivity toward stimulation, cells
were pretreated with IFN- for 3 h (white bars). In monocytes,
3pRNA (but not R848, CpG, or poly(I:C) (with or without trans-
fection)) induced IFN-. No increase was seen when monocytes
were primed with IFN- (Fig. 1A). Although monocytes do not
produce IFN- upon Lipofectamine-mediated transfection of
Table I. RNA sequencesa
Name Sequence 5 3 3
2.2 sense GCAUGCGACCUCUGUUUGA
9.1 sense UGGACGGCAACUGUUAUUA
9.1 antisense UAAUAACAGUUGCCGUCCA
9.2 sense AGCUUAACCUGUCCUUCAA
9.2 antisense UUGAsAGGACAGGUUAAGCU
9.3 sense ACCUGUCCUUCAAUUACCA
9.3 antisense UGGUAAUUGAAGGACAGGU
Ass AGCUUAACCUGU
Bss AACCUGUCCUUC
Lss AGCUUAACCUGUCCUU
Rss UUAACCUGUCCUUCAA
P20 UUGAAGGACAUGUCCUUCAA
P20-3Ma UGUCAGGACAUGUCCUUCAA
P20-5Ma UGUCCUGACAUGUCCUUCAA
P20-6Ma UGUCCUUACAUGUCCUUCAA
P20-20Ma UGUCCUUCAAUGUCCUUCAA
272 sense GCUGACCCUGAAGUUCAUCUGCACCACUU
272 antisense GUGGUGCAGAUGAACUUCAGGGUCAGCUU
270 sense AAGCUGACCCUGAAGUUCAUCUGCACC
270 antisense GGUGCAGAUGAACUUCAGGGUCAGCUU
GFPsb,c pppGGGGCUGACCCUGAAGUUCAUCUU
GAc pppGGGGGGGGGGGAAAAAAAAAAAA
a The self-complementary regions within the oligonucleotides are underlined.
b For GFPs a TLR7/8 motif is depicted in bold letters.
c These RNA oligonucleotides were generated by in vitro transcription.
Table II. DNA oligonucleotides (templates) for in vitro transcription
Name Sequence 5 3 3
2.2 sense TCAAACAGAGGTCGCATGCCTATAGTGAGTCG
2.2 antisense GCATGCGACCTCTGTTTGACTATAGTGAGTCG
GA TTTTTTTTTTTTCCCCCCCCCCCTATAGTGAGTCG
GFP-sense AAGATGAACTTCAGGGTCAGCCCTATAGTGAGTCG
GFP-antisense AAGCTGACCCTGAAGTTCATCCCTATAGTGAGTCG
Table III. siRNA sequences
Name Sequence 5 3 3
Luc sense CUUACGCUGAGUACUUCGAdTdT
Luc antisense UCGAAGUACUCAGCGUAAGdTdT
RIG-I sense AAGGCUGGUUCCGUGGCUUUUdTdT
RIG-I antisense AAAAGCCACGGAACCAGCCUUdTdT
TLR8 sense GGGAGUUACUGCUUGAAGAdTdT
TLR8 antisense UCUUCAAGCAGUAACUCCCdTdT
6826 RIG-I vs TLR ACTIVATION BY RNA OLIGONUCLEOTIDES
 at EPFL on M
ay 19, 2014
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
poly(I:C), monocytes do respond to poly(I:C) by up-regulating
IFN- mRNA within 4 h, suggesting that MDA5 is functional in
monocytes (data not shown). In mDC, 3pRNA induced low but
considerable amounts of IFN- (Fig. 1B). Poly(I:C) with and with-
out transfection only induced substantial amounts of IFN- in
mDC primed with IFN-. In pDC, 3pRNA induced much less
IFN- than CpG and R848, and no significant increase was seen
when pDC were primed with IFN- (Fig. 1C). No IFN- produc-
tion in response to 3pRNA was observed in primed or unprimed B
cells, T cells, or NK cells (data not shown). Although these ex-
periments showed that transfected 3pRNA was able to induce
IFN- in monocytes, mDC, or pDC, depletion of monocytes from
PBMC substantially diminished 3pRNA-triggered IFN- produc-
tion (Fig. 1D). The finding that monocytes were the main source of
3pRNA-mediated IFN- induction was further supported by the
analysis of IFN- production at the single cell level using intra-
cellular staining (Fig. 1E).
Distinct recognition pathways exist for 3pRNA in monocytes
and pDC
pDC, mDC, and monocytes were reported to detect RNA via
TLR7 and TLR8. Therefore, 3pRNA may activate these cells via
a TLR-dependent pathway. Previous studies have shown that
TLR7 mediates the recognition of RNA in a sequence-dependent
manner and that the minimal structural requirement for TLR7-
mediated recognition of RNA is the presence of uracil (5, 15). To
study the impact of the RNA sequence on the activity of
the 3pRNA molecule, we established two different versions of
3pRNA: 3pRNA GFPs contain a TLR7/8 stimulatory RNA motif;
3pRNA GA contains no uracil and lacks TLR7 activity (Table I).
We examined stimulation of monocytes and pDC with 3pRNA
GFPs in the presence of chloroquine, a potent inhibitor of TLR7-,
TLR8-, and TLR9-mediated nucleic acid recognition. No inhibi-
tory effect of chloroquine on IFN- production was seen in mono-
cytes transfected with 3pRNA GFPs (TLR7/8 activity) or with
3pRNA GA (Fig. 2A). In contrast, in pDC the presence of chlo-
roquine strongly impaired IFN- induction upon stimulation with
3pRNA GFPs, while 3pRNA GA-induced IFN- was much lower
but not sensitive to chloroquine. Similar data were obtained using
bafilomycin A, another inhibitor of lysosomal acidification (data
not shown). To directly address the role of TLR7 in the recognition
of 3pRNA in pDC, we examined IFN- induction in cultured pDC
from TLR7/ mice upon transfection with both synthetic ssRNA
2.2s (no triphosphate) and 3pRNA 2.2s in comparison to the re-
sponse observed with pDC from wild-type mice. As shown in Fig.
2B, wild-type pDC produced IFN- after transfection of synthetic
ssRNA 2.2s and 3pRNA 2.2s. In contrast, pDC from TLR7/
showed a strongly reduced IFN- production upon stimulation
with 3pRNA and no IFN- upon stimulation with ssRNA 2.2s.
This demonstrates that in pDC, TLR7 is required for recognition of
synthetic ssRNA and is responsible for most of the IFN- induc-
tion by 3pRNA. siRNA experiments conducted in human mono-
cyte-derived DCs showed that knocking down RIG-I expression
specifically reduced 3pRNA-triggered IFN- expression whereas
FIGURE 1. IFN- is induced in monocytes, mDC, and pDC upon stimulation with 3pRNA. A–C, Monocytes, mDC, and pDC were isolated from human
PBMC, primed with 500U/ml IFN- (white bars) for 3 h or left untreated (black bars). Cells were stimulated with CpG ODN 2216 (3 g/ml), R848 (5 g/ml),
poly(I:C) (10 g/ml), Lipofectamine alone, 3pRNA (200 ng), and poly(I:C) (200 ng), complexed with Lipofectamine, or left untreated. After 20 h of incubation,
supernatants were collected and assayed for IFN- production by ELISA. Data are expressed as the mean  SEM of four (monocytes, mDC) and
six (pDC) independent experiments. D, PBMC with or without CD14 monocytes were transfected with Lipofectamine alone or 3pRNA complexed
with Lipofectamine. No stimulus served as a control. Supernatants were collected 24 h after stimulation and IFN- was measured by ELISA. Mean 
SEM of two independent experiments is shown. E, Intracellular staining of IFN- is shown and plotted against CD14 surface staining. PBMC were
transfected with Lipofectamine alone or with Lipofectamine complexed with RNA 9.2-sense or 3pRNA and IFN- production was assessed by flow
cytometry after 7 h. Untreated PBMC () served as a control. Numbers represent IFN--positive cells out of the CD14-positive cell population. One
of two representative experiments is depicted. , Untreated.
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R848-mediated IL-12 production was not reduced (Fig. 2C). These
findings are consistent with the observation that RIG-I expression
in pDC was marginal (Fig. 2D). Further, MDA5 expression in pDC
was low. Altogether, these results indicated that monocytes and
pDC display distinct mechanisms for the recognition of
3pRNA. The observation that in pDC, TLR7 overrules RIG-I
for IFN- induction is in agreement with data obtained within
whole viruses in the murine system. In this regard, Kato et al.
have shown that Newcastle Disease Virus is recognized via
TLR7 whereas IFN-production in mDC and nonimmune cells is
RIG-I dependent (10).
3pRNA, but not synthetic blunt-end dsRNA oligonucleotides,
drives TLR-independent IFN- production
Previous studies have proposed that the presence of two nucleo-
tides (nt) overhangs at the 3 end acts as an inhibitory feature of
dsRNA oligonucleotides and prevents activation of RIG-I, whereas
blunt-end dsRNA oligonucleotides induces immunostimulation
(14). In a previous work, we have shown that the presence of a two
nt overhang did not change the IFN- inducing activity of a
triphosphate dsRNA oligonucleotide. To further characterize the
effect of the terminal conformation of short dsRNA for IFN-
induction, we studied pDC activation by blunt-end and overhang
dsRNA. The respective ssRNAs were used as controls. In this
respect, we found that both types of synthetic dsRNA were equally
active in pDC, regardless of whether a two nt overhang was
present or not (Fig. 3A). In contrast, when we transfected mono-
cytes with blunt-end and overhang dsRNA, but no triphosphate, no
IFN- response was detected (Fig. 3B). Instead, IFN- production
in monocytes strictly required the presence of a triphosphate at the
5 end. This was also the case when IFN- production was assessed
at the transcriptional level (Fig. 3C). Together, these results indicated
that activation of the TLR system in pDC rather than RIG-I is re-
sponsible for IFN- production upon stimulation with blunt-end
dsRNA (no triphosphate 5 end) in primary immune cells.
The type of RNA delivery determines cell-type specific cytokine
responses
The findings above showed that chemically synthesized RNA with
no triphosphate end failed to stimulate monocytes to produce
IFN-. However, studies by other groups using different methods
of delivery suggested that synthetic ssRNA activates monocytes in
a TLR-dependent manner (3, 4, 16, 29). This prompted us to in-
vestigate whether the use of transfection reagents influenced the
stimulatory potential of RNA. Therefore an alternative method to
effectively complex RNA based on the polycationic peptide pLa
was established. PBMC (containing both pDC and monocytes)
were stimulated with increasing doses of RNA 9.2-sense or
3pRNA using distinct modes of delivery (Lipofectamine vs pLa).
Although all RNA complexes tested induced IFN- to some ex-
tent, 3pRNA transfected with Lipofectamine was by far the most
potent stimulus (Fig. 4A, left panel). The effect of Lipofectamine-
complexed 3pRNA was not inhibited by chloroquine (Fig. 4A, left
panel, white bars); however, chloroquine inhibited IFN- induced
by both RNA 9.2-sense and 3pRNA complexed with pLa (Fig. 4A,
FIGURE 2. Recognition of 3pRNA occurs through differential pathways in monocytes and pDC. A, Monocytes and pDC were preincubated with 1000
ng/ml chloroquine (white bars) or left untreated (black bars). After 30 min, cells were stimulated with 3pRNA GA or 3pRNA GFPs complexed with
Lipofectamine or control (no stimulus, ). Supernatants were collected 20 h post-stimulation and IFN- production was determined by ELISA. Mean 
SEM of two independent experiments is shown. B, Sorted pDC from Flt3 ligand-induced bone marrow cultures of wild-type (WT; black bars) and
TLR7-deficient mice (TLR7/; white bars) were transfected with synthetic ssRNA 2.2-sense (ssRNA 2.2s), 3pRNA 2.2-sense (3pRNA 2.2s), or CpG 2216
(3 g/ml). After 24 h, supernatants were collected and IFN- production was quantified by ELISA. Data are expressed as the mean  SEM of two
independent experiments. C, Monocyte-derived DC were electroporated with siRNA directed against RIG-I or control siRNA. Forty-eight hours after
electroporation, cells were transfected with 3pRNA complexed to Lipofectamine. No stimulus, Lipofectamine alone, and R848 (5 g/ml) served as control.
Supernatants were collected 24 h after transfection and cytokines were quantified by ELISA. Mean  SEM of two independent experiments is depicted.
D, pDC and monocytes were isolated from human PBMC and relative expression of RIG-I, MDA5, and TLR9 was determined by quantitative real-time
PCR. Mean  SEM of two independent experiments is depicted. , Untreated.
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left panel, white bars). In purified monocytes, only Lipofectamine-
transfected 3pRNA and not pLa delivered 3pRNA-induced IFN-
(Fig. 4A, right panel). However, the analysis of proinflammatory
cytokines in the supernatants of transfected monocytes showed an
opposite picture with strong induction of IL-12p70 by pLa and
3pRNA but no IL-12p70 induction by Lipofectamine (Fig. 4B). Of
note, pLa RNA-triggered IL-12p70 production in PBMC was
highly dependent on the presence of monocytes (Fig. 4C). Next to
IL-12p70 production, several key proinflammatory cytokines were
almost exclusively seen for pLa-mediated delivery of RNA (Fig.
5). Among those were TNF-, IL-6, IL-12p40, and IL-1, which
were only observed when RNA was delivered using pLa and not
Lipofectamine. A similar cytokine profile to pLa-complexed RNA
was seen for the TLR7/8 ligand R848 (data not shown). Alto-
gether, these data suggested that the type of delivery impacts on
the subsequent cytokine response.
FIGURE 3. Blunt-end dsRNA is a
poor inducer of type I IFN in mono-
cytes. A and B, Synthetic ssRNA (27
0 sense (s), 27  0 antisense (a), 27 
2 sense, 27  2 antisense) and dsRNA
with (27  2 double-strand (ds)) or
without (27  0 double-strand) two nt
overhangs were transfected into pDC
and monocytes in complex with Lipo-
fectamine. ODN 2216 (3 g/ml) or
3pRNA (200 ng) were used as a control
stimulus for IFN- or RIG-I, respec-
tively. The levels of IFN- production
were analyzed by ELISA 24 h after
stimulation and are depicted as mean
SEM of two independent experiments.
C, Human monocytes were transfected
with 3pRNA or synthetic dsRNA with
(27  2 double-strand) or without
(27  0 double-strand) two nt over-
hangs using Lipofectamine as a trans-
fection reagent. Lipofectamine alone
was used as control. After 4 h, relative
expression of IFN- mRNA was deter-
mined by quantitative real-time PCR.
Mean  SEM of four independent ex-
periments is shown. , Untreated.
FIGURE 4. The mode of delivery
differentially regulates subsequent cy-
tokines responses in monocytes. A,
PBMC or monocytes were stimulated
with increasing doses (100 ng, 200
ng, and 400 ng) of 3pRNA and RNA
9.2-sense (se) complexed with Lipo-
fectamine or pLa alone (black bars) or
in the presence of 1000 ng/ml chloro-
quine (white bars only PBMC). After
20 h, IFN- production was measured
by ELISA. Mean  SEM of two in-
dependent experiments is shown. B,
pLa and Lipofectamine were incu-
bated with 3pRNA and tested for
stimulatory activity in human mono-
cytes. Supernatants were collected af-
ter 24 h to measure IL-12p70 and
IFN- production by ELISA (mean
SEM, n  2). C, PBMC with or with-
out CD14 monocytes (left panel)
and PBMC with or without pDC,
mDC, or both (right panel) were
transfected with RNA 9.2-sense com-
plexed with pLa and IL-12p70 was
measured 24 h after stimulation.
Mean SEM of two independent ex-
periments is shown. , Untreated.
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pLa-mediated transfection results in prolonged endosomal
signaling, which is required for efficient TLR8-dependent IL-12
production
Given the striking differences in the cytokine response observed
for pLa and Lipofectamine, we next sought to study whether the
mode of delivery influences the intracellular distribution of
RNA oligonucleotides. To follow the uptake process of ssRNA
complexes in monocytes, we performed microscopy studies in
monocytes using fluorescein-tagged ssRNA (FITC-RNA).
Monocytes were incubated with FITC-RNA in complex with
Lipofectamine or pLa for 120 min and 180 min, and colocal-
ization with the endosomal marker EEA-1 was analyzed. We
observed colocalization of EEA-1 with FITC-RNA after both
120 min and 180 min of incubation when pLa was used for
transfection (Fig. 6). In contrast, no colocalization was seen
after transfection with Lipofectamine. Instead, transfection with
Lipofectamine resulted in a predominant translocation of FITC-
RNA into the cytoplasm. These results indicated that pLa but
not Lipofectamine complexes are retained in endosomal com-
partments and that only Lipofectamine delivers RNA into the
cytosol. The fact that pLa results in a prolonged endosomal
retention of RNA prompted us to investigate whether a TLR-
mediated mechanism would be involved in the recognition of
RNA. To address this question we pretreated PBMC with chlo-
roquine to inhibit endosomal maturation. We found that the
IL-12p70 response was highly sensitive to the inhibition with
chloroquine, whereas IFN- production induced by 3pRNA com-
plexed with Lipofectamine was not inhibited (Fig. 7A). Given its
high and predominant expression in monocytes, TLR8 was the
most likely candidate receptor for the recognition of pLa-com-
plexed RNA. To address this question, we performed siRNA
knock-down experiments in human monocyte-derived dendritic
cells. Notably, the induction of IL-12 by pLa-complexed ssRNA
was markedly reduced after pretreatment with anti-TLR8 siRNA
FIGURE 5. Cytokine profile of 3pRNA
vs synthetic ssRNA in human PBMC.
PBMC were transfected with RNA 9.2-sense
(se) complexed with pLa or 3pRNA com-
plexed with Lipofectamine or left untreated.
Supernatants were collected 24 h after stim-
ulation and cytokines were detected by
ELISA. Mean  SEM of three independent
experiments is shown. , Untreated.
FIGURE 6. ssRNA in complex with Lipofectamine rapidly translocates
into the cytoplasm, whereas pLa complexed ssRNA is retained in endoso-
mal compartments. Fluorescent images of monocytes transfected with
FITC-labeled ssRNA 9.2-sense (FITC-RNA) complexed to pLa or Lipo-
fectamine and incubated for the indicated durations. Fixed cells were
stained with EEA-1 (rhodamine-red-X) to mark endosomes and nuclear
counterstaining was performed using TOPRO-3.
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(Fig. 7B, left panel). At the same time, IFN- levels induced by
Lipofectamine-mediated transfection of 3pRNA remained unaf-
fected by siRNA targeting TLR8 (Fig. 7B, right panel). The su-
periority of pLa over Lipofectamine for the activation of TLR8 by
RNA was in line with the predominant localization of pLa RNA
complexes in the endolysosomal compartment. Accordingly, we
found that in pDC, where RNA recognition is based on TLR7,
delivery of 3pRNA with pLa was more potent in type I IFN
FIGURE 7. Directed endolysosomal
delivery activates TLR8 in monocytes. A,
PBMC were preincubated with chloro-
quine for 30 min and subsequently stim-
ulated with RNA 9.1-sense (se) in com-
plex with pLa or 3pRNA complexed with
Lipofectamine, respectively, or left un-
treated. IL-12p70 or IFN- production
was analyzed by ELISA 24 h after stim-
ulation (mean SEM, n 2). B, Mono-
cyte-derived DCs were electroporated
with siRNA against TLR8 or control
siRNA. Cells were transfected with RNA
9.2-sense complexed with pLa, pLa
alone, Lipofectamine alone, and 3pRNA
complexed with Lipofectamine. Superna-
tants were collected 24 h after transfec-
tion and cytokines were quantified by
ELISA. Mean  SEM of two experi-
ments is shown. C, pDC were stimulated
with 3pRNA complexed with Lipo-
fectamine or pLa. After 20 h IFN- pro-
duction was measured by ELISA.
Mean SEM of two independent exper-
iments is shown. , Untreated.
FIGURE 8. Selection of structure and sequence for the induction of IL-12 or IFN-. A, Monocytes were transfected with different versions of ssRNA
and dsRNA using pLa as indicated. Supernatants were collected and subjected to ELISA for determination of IL-12p70 production 24 h after transfection.
Mean  SEM of three independent experiments is shown. B, Different versions of RNA 9.2-sense (s) were annealed with 9.2-antisense (as) to form partial
or complete RNA duplexes and subsequently transfected into PBMC using pLa. The respective ssRNA molecules served as controls, whereas the sense
strand was used for normalization. After 24 h supernatants were analyzed for IL-12p70 and IFN- production (mean  SEM, n  2). C and D, PBMC
were transfected using pLa with a self-complementary ssRNA (P20) and a panel of its derivatives containing an increasing number of mismatches within
the complementary regions (P20-3M, P20-5M, P20-6M, and P20-20M). CpG A 2216 (3 g/ml) and R848 (5 g/ml) served as controls. Supernatants were
analyzed for IL-12p70 and IFN- production 24 h post stimulation (mean  SEM, n  2). , Untreated.
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induction than Lipofectamine (Fig. 7C). Collectively, these exper-
iments showed that the method of delivery of RNA per se critically
determines the initial recognition pathway in monocytes.
Single-strand conformation is required for maximal IL-12
production by RNA in monocytes
Based on the observation that pLa exclusively targets RNA to
the endosome but not the cytosol, we further characterized the
structural requirements for TLR-mediated recognition of RNA.
Previous studies demonstrated that in immune cells, TLR7 and TLR8
contribute to RNA recognition. In pDC (exclusively expressing
TLR7), both ssRNA and dsRNA oligonucleotides (siRNA, sense and
antisense strand) induce IFN- in a sequence-dependent manner (5).
Based on these earlier observations, we compared the activity of dif-
ferent short dsRNA and the respective sense and antisense strands
complexed with pLa to induce IL-12p70 in monocytes. Although the
sense and the antisense ssRNA oligonucleotides were active at induc-
ing IL-12p70, the corresponding dsRNA oligonucleotides did not in-
duce IL-12p70 (Fig. 8A). To further clarify conformation require-
ments, partial dsRNA oligonucleotides were generated by annealing
short derivatives of the 9.2-sense strand to the respective complete
9.2-antisense strand and used for stimulation of PBMC. Partial 12mer
duplexes, partial 16mer duplexes, a complete 21mer duplex, and the
corresponding ssRNAs were analyzed (Fig. 8B). A short portion of
dsRNA conformation was sufficient to reduce IL-12 induction of a
potent ssRNA oligonucleotide (Fig. 8B, for example compare 9.2-
antisense to Ads or Bds). In contrast, high stimulation of IFN- was
seen with a partial (Fig. 7B, for example, Ads and Bds) or full RNA
duplex (Fig. 8B, 9.2 double strand). A 12mer ssRNA was not suffi-
cient to induce IL-12p70 and IFN-, but limited activity was seen
with 16mer ssRNA (Fig. 8B). To further address the role of RNA
structure in TLR-dependent activation of monocytes, we designed a
fully self-complementary ssRNA oligonucleotide that forms a dsRNA
under physiological conditions. We found that this self-complemen-
tary ssRNA was active in inducing IFN- in PBMC, however it
lacked the ability to induce IL-12p70 (Fig. 8C). We next asked what
degree of single-strandedness within this self-complementary RNA
was required to restore IL-12 induction. Therefore we gradually in-
creased the number of mismatches within the complementary re-
gions. Testing this panel of RNA oligonucleotides revealed that
an increasing number of mismatches was associated with a
higher level of IL-12 induction, while decreasing IFN- induc-
tion (Fig. 8D). Notably, an introduction of three mismatches
was sufficient to markedly reduce IFN- production, while
markedly enhancing IL-12 production. The nonlinear increase
of IL-12 induction with increasing numbers of mismatches may
be due to changes in the TLR8 sequence motif activity. To-
gether, these data suggested that ss- but not dsRNA is required
for optimal TLR-dependent stimulation in monocytes (IL-12).
Discussion
The vertebrate immune system has established versatile ways to
sense invading viruses based on certain molecular patterns of viral
nucleic acids. Several receptors participate in a nonredundant sys-
tem to master the recognition of foreign RNA (1). Ligand speci-
ficity, distinct expression profiles, subcellular localization, and dis-
tinct downstream signaling pathways explain the ability of these
receptor systems to elicit appropriate immune responses. In this
study we aimed at dissecting these different components to identify
optimal compositions of immunologically active oligoribonucleo-
tide complexes.
Our results demonstrate that, in addition to the sequence, both
the structure and the type of delivery determine the stimulatory
potential of RNA oligonucleotides. By comparing different trans-
fection techniques, we observed that the mode of delivery dramat-
ically directs the subsequent cytokine responses by determining
the access of the RNA to the respective receptors. Although cy-
tosolic delivery by Lipofectamine was required to activate RIG-I
in monocytes, endosomal delivery through pLa allowed the acti-
vation of the TLR7 and the TLR8 pathway in pDC and monocytes,
respectively. Activation of RIG-I by RNA oligonucleotides re-
quired a triphosphate at the 5 end and activation of TLR8 in
monocytes required single-strand conformation.
Given the strong type I IFN response upon transfection of 5
triphosphate RNA in PBMC, we sought to identify the immune
cell subsets that were responsible for this activity. Using mice
genetically deficient in TLR7, siRNA-targeting TLR8, and a
3pRNA molecule lacking TLR7/8 activity (3pRNA GA), blocking
endolysosomal nucleic acid recognition and specifically targeting
nucleic acid complexes to distinct cellular compartments, we con-
cluded that 3pRNA is sensed in a clearly cell-type specific manner;
cytosolic detection of 3pRNA by RIG-I leads to a robust IFN-
response in monocytes and mDC, but not in pDC. Blocking en-
dolysosomal nucleic acid recognition (chloroquine) or using a
3pRNA molecule with no TLR7/8 activity (3pRNA GA) did not
diminish the type I IFN response in monocytes. Consequently,
positioning 3pRNA exclusively in endosomal compartments of
monocytes (polycationic peptides) does not lead to an IFN re-
sponse. Finally, siRNA experiments substantiate that in myeloid
cells IFN- induction is exclusively due to RIG-I and not to
TLR7/8. An opposite picture is seen for pDC. 3pRNA readily in-
duces IFN-, but this is due to sensing by TLR7 and occurs in-
dependently of its 5 triphosphate end. RNA without a 5 triphos-
phate induces IFN- in pDC equally potently and chloroquine
reduces this response. Moreover, delivery of 3pRNA containing
TLR7 ligand activity to the endosomal compartment of pDC by
pLa was even more potent than transfection with cationic lipids. In
line with these observations, we found that RIG-I is only margin-
ally expressed in pDC when compared with monocytes. Support-
ing this concept of cell-type specific involvement of RIG-I for
RNA detection, pDC from RIG-I deficient mice challenged with
the RNA virus Newcastle Disease Virus were reported to show
normal production of IFN-, while no IFN- could be induced in
RIG-I-deficient mDCs and mouse embryonic fibroblasts (10). Of
note, Kato et al. proposed a residual activity of RIG-I in pDC, a
concept that is supported by our findings. Thus, being responsible
for the early type I IFN response in viral infection, pDC seem to
mostly but not exclusively rely on TLR-dependent recognition of
RNA viruses.
Using polycationic peptides to directly deliver RNA oligonu-
cleotides into endosomal compartments leads to the notable ob-
servation that large quantities of bioactive IL-12p70 can be in-
duced in monocytes by a single TLR agonist, pLa-complexed
ssRNA. So far DC are thought to represent the major source of
IL-12p70. However, IL-12p70 production within DC is known to
be tightly controlled, usually requiring multiple stimuli to syner-
gize and to induce its expression (30). In fact, we identified mono-
cytes as the major source of IL-12p70 upon ssRNA stimulation
within PBMC. The exclusive expression of TLR8 in monocytes
(24, 30), sensitivity toward inhibition by chloroquine, and siRNA-
mediated knock-down experiments support the concept of TLR8-
dependent recognition of RNA-pLa complexes to be responsible
for massive IL-12p70 induction. This previously unappreciated ca-
pability of monocytes to produce large amounts of IFN- and IL-
12p70 can be used to establish and maintain potent Th1 immune
responses.
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Interestingly, TLR8-mediated recognition of RNA oligonucleo-
tides strictly requires single-strand conformation of RNA in mono-
cytes. Any structural alteration in the RNA leading to even partial
double-strand conformations abolishes the activity of RNA in
monocytes. It is tempting to speculate that the receptor molecules
(TLR7 and TLR8) themselves are responsible for the ability to
detect different RNA conformations. Besides TLR7 and TLR8,
pDC- and monocyte-specific cofactors may contribute to differen-
tial TLR response to ssRNA and dsRNA.
In conclusion, our data demonstrate that introducing or avoiding
certain molecular patterns, such as a 5 triphosphate group,
TLR7/8 motif, and ssRNA or dsRNA conformation, combined
with specific types of delivery (cytoplasmic and endosomal) and
sequence motifs allows the modular design of immunostimulatory
RNA oligonucleotides that trigger specific receptor systems, pro-
voking distinct downstream immune responses, including potent
IL-12 and IFN- induction in monocytes. This information will
facilitate the rational design of RNA-based drugs.
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